Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Wellcome Trust announced that Prof Andrew Wilkie has been give a Senior Investigator Award. These highly competitive awards provide funding for scientists who have an excellent track record and are in an established academic post. They offer the flexibility and time to enable them to tackle the most important questions in their field. Prof Wilkie's research focuses on "Mutations in malformation and disease".

Logo of the Wellcome Trust.


In particular Prof Wilkie will study mutation and its effects in two distinct but complementary ways. First, he will search for new genes or mutational mechanisms in one particular group of clinically important malformations affecting the skull and face. This work will provide new diagnoses and genetic counselling for affected families. Second, he will analyse the way that certain mutations arise in men's testes and can become enriched over time, increasing the risk that they will be transmitted to children. These seemingly disparate approaches are unexpectedly linked because the body uses the same signalling mechanisms in the very different contexts of the skull and the reproductive cells. Over the five year period of this proposal, the aim is to broaden the scope of previous investigations and seek evidence that similar mechanisms may shape the occurrence of mutations in a wider range of diseases, including some cancers and neurodevelopmental conditions such as autism and schizophrenia.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.